InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,316.82
(
0.16%
)
US TECH 100
18,200.80
(
0.02%
)
Dow Jones
39,857.54
(
0.13%
)
Brent Oil
82.78
(
-0.90%
)
Bitcoin
69,825.13
(
-2.26%
)
Post# of 693040
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

jimmy667

Send PM Follow Ignore
Followers 105
Posts 4947
Boards Moderated 0
Alias Born 10/20/2015

jimmy667

Re: biosectinvestor post# 508602

Saturday, 08/27/2022 8:01:24 PM

Saturday, August 27, 2022 8:01:24 PM

Post# of 693040
It trials such as the Keytruda/UCLA ATL-Vax (experimental version of NWBO drug) where ATL-Vax is the Placebo arm, the standard of care drug is chosen as the Placebo.
So is not Merck projecting or calculating that DC-Vax is highly likely to be the SOC by the time the Combo trial sequence reaches the Phase 3 Registration trial development stage.
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent NWBO News
More NWBO News
InvestorsHub NewsWire

"Defo's Morning Briefing" Set to Debut for "GreenliteTV" • GRNL • May 21, 2024 2:28 PM

North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM

Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM

Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM

VPR Brands (VPRB) Reports First Quarter 2024 Financial Results • VPRB • May 17, 2024 8:04 AM

ILUS Provides a First Quarter Filing Update • ILUS • May 16, 2024 11:26 AM

Start posting your company's news
Only $200 per official company press release!